Periphere arterielle Verschlusskrankheit (PAVK) – S3-Leitlinie Diagnostik und Therapie

Der Beitrag stellt die wesentlichsten Aspekte der neuen S3-Leitlinie zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK) dar [1]. Diese betreffen die Definition und Epidemiologie der PAVK, die Diagnostik mittels klinisch-angiologischer Methoden, apparativer angiologischer sowie bildgebender Verfahren, die Therapie mittels konservativer, interventioneller und chirurgischer Methoden sowie die Nachsorge der Patienten. In Kernaussagen werden Empfehlungen gegeben, deren Empfehlungsgrad von der wissenschaftlichen Evidenz, d. h. von den Ergebnissen klinisch-wissenschaftlicher Studien und anderer Literaturberichte abgeleitet wurde.

This report summarizes the most important aspects of the new German S3-guidelines for diagnostic and treatment of peripheral arterial occlusive disease. This includes, definitions and epidemiology of peripheral arterial occlusive disease, diagnostic methods including clinical and technical procedures as well as imaging methods, treatment by non-invasive, interventional and surgical methods and patient care during follow-up. In key-messages recommendations are given which are graded corresponding to the scientific evidence concluded from the literature.

Key words

Peripheral arterial occlusive disease - peripheral angioplasty - claudication - vascular surgery - critical limb ischemia

• Literatur

• 1 Lawall H, Diehm C Pittrow Hrsg. Deutsche Gesellschaft für Angiologie, Gesellschaft für Gefäßmedizin. Leitlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK). VASA (Suppl. 75) 2009; 38: 1-72
• 2 Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985; 71: 510-5
• 3 Diehm C, Schuster A, Allenberg H, Darius H, Haberl R et al. High prevalence of peripheral arterial disease and comorbidity in 6,880 primary care patients: cross sectional study. Atherosclerosis 2004; 172: 95-105
• 4 Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994; 1: 333-9
• 5 Steg PG, Bhatt DL, Wilson PW, DÀgostino Sr. R, Ohman EM et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297: 1197-206
• 6 Diehm C, Allenberg J-R, Haberl R, Darius H, Mahn M et al. High all-cause mortality in patients with peripheral arterial disease in primary care: Five-year results of the getABI study [abstract 3701]. Circulation 2007; 116
• 7 Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW et al. Bypass versus angioplasty in severe ischaemia oft the leg (BASIL): multicentre, randomised controlled trial. Lancet 2005; 366: 1925-34
• 8 Conte MS, Belkin M, Upchurch GR, Mannick JA, Whittemore AD et al. Impact of increasing comorbidity on infrainguinal reconstruction: a 20-year perspective. Ann Surg 2001; 233: 445-52
• 9 Norgren L, Hiatt W, Dormandy J, Nehler M, Harris K et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg (Suppl. 01) 2007; 33
• 10 Tefera G, Turnipseed W, Tanke T. Limb salvage angioplasty in poor surgical candidates. Vasc Endovascular Surg 2003; 37: 99-104
• 11 Lofberg AM, Karacagil S, Ljungman C, Westman B, Bostrom A. Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical lower limb ischemia. J Vasc Surg 2001; 34: 114-21
• 12 Faglia E, Mantero M, Caminiti M, Caravaggi C, De Giglio R et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 2002; 252: 225-32
• 13 Dorros G, Jaff MR, Dorros AM, Mthiak LM, He T. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation 2001; 104: 2057-62
• 14 Faglia E, Dalla PaolaL, Clerici G, Clerissi J, Graziani L. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 2005; 29: 620-7
• 15 Sigala F, Georgopoulos S, Langer S, Baunach C Papalambros et al. Outcome of infrainguinal revascularization for critical limb ischemia in diabetics with end stage renal disease. VASA 2006; 35: 15-20
• 16 Nasr MK, McCarthy RJ, Hardman J, Chalmers A, Horrocks M. The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia. Eur J Vasc Endovasc Surg 2002; 23: 398-403
• 17 Wagner HJ. Current status of endovascular therapy in the femoropopliteal vascular segment in chronic peripheral arterial occlusive disease. VASA 2002; 31: 153-61
• 18 Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006; 354: 1879-88
• 19 Muradin GS, Bosch JL, Stijnen T, Hunink MG. Balloon dilatation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 2001; 221: 137-45
• 20 Kudo T, Chandra FA, Kwun WH, Haas BT, Ahn SS. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg 2006; 44: 304-13
• 21 Soder HK, Manninen HI, Jaakkola P, Matsi PJ, Rasanen HT. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol 2000; 11: 1021-31
• 22 Balmer H, Mahler F, Do DD, Triller J, Baumgartner I. Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome. J Endovasc Ther 2002; 9: 403-10
• 23 Lugmayr HF, Holzer H, Kastner M, Riedelsberger H, Auterith A. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up. Radiology 2002; 222: 37-43
• 24 Jahnke T, Voshage G, Mueller-Huelsbeck S, Grimm J, Heller M. Endovascular placement of self-expanding nitinol coil stents for the treatment of femoropopliteal obstructive disease. J Vasc Interv Radiol 2002; 13: 257-66
• 25 Duda S, Heller S, Wiesinger B, Tepe G. Modifizierte Stents für interventionelle Therapie der PAVK. VASA (Suppl. 64) 2004; 55-9
• 26 Arena FJ. Arterial kink and damage in normal segments of the superficial femoral and popliteal arteries abutting nitinol stents - a common cause of late occlusion and restenosis? A single-center experience. J Invasive Cardiol 2005; 17: 482-6
• 27 Babalik E, Gulbaran M, Gurmen T, Ozturk S. Fracture of popliteal artery stents. Circ J 2003; 67: 643-5
• 28 Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005; 45: 312-5
• 29 de Vries SO, Hunink MG. Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis. J Vasc Surg 1997; 26: 558-69
• 30 Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, Harrington DP. Patency results of percutaneous and surgical revascularization for femoropopliteal artery disease. Med Decis Making 1994; 14: 71-81
• 31 Gentile AT, Lee RW, Moneta GL, Taylor LM, Edwards JM. Results of bypass to the popliteal and tibial arteries with alternative sources of autogenous vein. J Vasc Surg 1996; 23: 272-9
• 32 Albers M, Battistella VM, Romiti M, Rodrigues AA, Pereira CA. Meta-analysis of polytetrafluoroethylene bypass grafts to infrapopliteal arteries. J Vasc Surg 2003; 37: 1263-9
• 33 Albers M, Romiti M, Brochado-Neto FC, De Luccia N, Pereira CA. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg 2006; 43: 498-503
• 34 Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994; 220: 251-66
• 35 Ouriel K, Shortell CK, DeWeese JA, Green RM, Francis CW. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 1994; 19: 1021-30
• 36 Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 1998; 338: 1105-11
• 37 Sobel M, Verhaeghe R. Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; (Suppl. 01) 133: 815-43
• 38 Do DD, Mahler F. Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty. Radiology 1994; 193: 567-71
• 39 Pilger E, Lammer J, Bertuch H, Strak G, Decrinis M. Nd:YAG laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions. Long-term results. Circulation 1991; 83: 141-7
• 40 Schneider E, Mahler F, Do DD. Zur Rezidivprophylaxe nach perkutaner transluminaler Angioplastie (PTA): Antikoagulation versus Ticlopidin. VASA 1987; 16 (Suppl. 01) 355-6
• 41 Kopp I, Lelgemann M, Ollenschlaeger G. EbM und Leitlinien. In: Kunz R, et al. Hrsg. Lehrbuch Evidenzbasierte Medizin in Klinik und Praxis. Auflage Köln: Deutscher Ärzteverlag; 2007. 2.